Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment RecommendationsArticle Published on 2024-03-042024-09-04 Journal: The Journal of rheumatology [Category] 대상포진, [키워드] GRAPPA psoriasis psoriatic arthritis [DOI] 10.3899/jrheum.220317 PMC 바로가기 [Article Type] Article
The Risk of Herpes Zoster Events in Patients with Spondyloarthritis and the Effect of BNT162b2 mRNA COVID-19 VaccineArticle Published on 2024-01-152024-09-05 Journal: Vaccines [Category] update2024, [키워드] ankylosing spondylitis COVID-19 herpes zoster mRNA vaccine psoriatic arthritis spondyloarthritis [DOI] 10.3390/vaccines12010085 PMC 바로가기 [Article Type] Article
Pediatric Psoriasis with or without Arthritis: Does It Make a Difference?Article Published on 2023-12-312024-09-04 Journal: Journal of Clinical Medicine [Category] 대상포진, [키워드] joints juvenile inflammatory arthritis pediatrics psoriasis psoriatic arthritis systemic [DOI] 10.3390/jcm13010242 PMC 바로가기 [Article Type] Article
Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic ArthritisOriginal Paper Published on 2023-12-302024-09-04 Journal: Mediterranean Journal of Rheumatology [Category] 대상포진, [키워드] bDMARDs Comorbidities Minimal disease activity psoriatic arthritis registry [DOI] 10.31138/mjr.301223.dpa PMC 바로가기 [Article Type] Original Paper
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL studyPsoriatic Arthritis Published on 2023-11-112024-09-04 Journal: Annals of the rheumatic diseases [Category] 대상포진, [키워드] Arthritis, Psoriatic biological therapy psoriatic arthritis [DOI] 10.1136/ard-2023-224431 PMC 바로가기 [Article Type] Psoriatic Arthritis
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter studyarticle Published on 2023-10-112024-09-02 Journal: Arthritis Research & Therapy [Category] 대상포진, [키워드] Axial inflammation Bio-refractory Clinical efficacy Minimal disease activity Peripheral arthritis psoriasis psoriatic arthritis real life Safety Upadacitinib [DOI] 10.1186/s13075-023-03182-9 PMC 바로가기 [Article Type] article
The Effect of an Interdisciplinary Dermatological-Rheumatological Consultation on the Outcome of Patients with Psoriasis with Musculoskeletal Pain: A Prospective, Single-Center Cohort StudyOriginal Research Published on 2023-09-282024-09-05 Journal: Advances in therapy [Category] update2024, [키워드] Dermatological-rheumatological consultation disease management Interdisciplinary consultation mental health mHealth psoriasis psoriatic arthritis [DOI] 10.1007/s12325-023-02667-y PMC 바로가기 [Article Type] Original Research
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsArticle Published on 2023-03-272024-09-05 Journal: medRxiv [Category] update2024, [키워드] COVID-19 mRNA vaccine psoriatic arthritis Sjögren’s syndrome systemic lupus erythematosus [DOI] 10.1101/2023.03.22.23287597 PMC 바로가기 [Article Type] Article
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER studyOriginal research Published on 2023-03-162024-09-05 Journal: RMD open [Category] update2024, [키워드] COVID-19 psoriatic arthritis rheumatoid arthritis vaccination [DOI] 10.1136/rmdopen-2022-002936 PMC 바로가기 [Article Type] Original research
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort studyArticle Published on 2022-10-052022-11-15 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI analyzed anti-RBD antibodies binding antibody antibody level blood sample bowel collected combination treatment Control controls COVID-19 declined defined disease dose enrolled Factor greater healthy healthy control healthy individuals Humoral immunity identify Immune-mediated inflammatory disease immunosuppressive Immunosuppressive medication Inflammatory bowel disease inhibitor initial interval median Multivariable regression Necrosis participant Patient patients persistence prospective cohort study Protein provided psoriatic arthritis RBD reduction reduction in Rheumatic diseases rheumatoid arthritis SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine serologic Serologic response spike spondyloarthritis Support the receptor-binding domain the SARS-CoV-2 Therapies therapy ulcerative colitis vaccination vaccine dose [DOI] 10.1186/s12916-022-02587-8 PMC 바로가기